Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 436 entries
View as:

Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06360471 Org: User:
Start: 10/01/23 End: 10/01/32 Due: 10/01/33

Rapid Detection of Pseudomonas Aeruginosa in Bronchoalveolar Lavage Fluid Using Label-free Single-particle Imaging Technology and Assessment of Post-treatment Efficacy in Patients With Pseudomonas Aeruginosa Infection

Phase: N/A Priority: Normal
NCT ID: NCT06986512 Org: User:
Start: 07/01/25 End: 11/30/25 Due: 11/30/26

Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05347641 Org: User:
Start: 06/01/22 End: 06/01/29 Due: 06/01/30

Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy

Phase: N/A Priority: Normal
NCT ID: NCT01892059 Org: User:
Start: 05/31/13 End: 05/31/16 Due: 05/31/17

LLTS to Treat Premature Ventricular Contractions

Phase: N/A Priority: Normal
NCT ID: NCT04909528 Org: User:
Start: 03/15/21 End: 12/31/22 Due: 12/31/23

Sintilimab in Combination With R-CHOP in Patients With Treatment-naive EBV-positive DLBCL, NOS

Phase: N/A Priority: Normal
NCT ID: NCT04181489 Org: User:
Start: 01/01/19 End: 12/30/23 Due: 12/30/24

Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04683965 Org: User:
Start: 01/01/21 End: 05/01/24 Due: 05/01/25

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Phase: N/A Priority: Normal
NCT ID: NCT07036731 Org: User:
Start: 02/01/25 End: 08/31/29 Due: 08/31/30

Trial of FFP+HDMP+Rituximab for Ultra-high Risk Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01670812 Org: User:
Start: 01/31/12 End: 06/30/14 Due: 06/30/15

A Clinical Observation on Electrophysiology in Headache Patients With Myofascial Trigger Points

Phase: N/A Priority: Normal
NCT ID: NCT03890393 Org: User:
Start: 01/01/18 End: 12/31/18 Due: 12/31/19

Lenalidomide, Rituximab, Gemcitabine, Oxaliplatin and Dexamethasone in Relapse and Refractory DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT03795571 Org: User:
Start: 01/01/19 End: 12/31/19 Due: 12/31/20

OCT in Borderline Coronary Artery Lesions

Phase: N/A Priority: Normal
NCT ID: NCT03229993 Org: User:
Start: 12/31/17 End: 12/31/19 Due: 12/31/20

Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML

Phase: N/A Priority: Normal
NCT ID: NCT05584761 Org: User:
Start: 03/01/22 End: 12/31/26 Due: 12/31/27

Application of a New X-ray Protective Device in Coronary Interventional Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05088291 Org: User:
Start: 09/30/21 End: 07/30/22 Due: 07/30/23

Medical Tai Chi Exercise Healing in Treating mCRC Patients

Phase: N/A Priority: Normal
NCT ID: NCT06104267 Org: User:
Start: 09/01/23 End: 12/31/24 Due: 12/31/25

The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens

Phase: N/A Priority: Normal
NCT ID: NCT07035535 Org: User:
Start: 01/01/23 End: 12/31/25 Due: 12/31/26

Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT05700266 Org: User:
Start: 12/30/23 End: 12/31/24 Due: 12/31/25

Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation to Treat Chronic Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01716143 Org: User:
Start: 03/31/10 End: 12/31/12 Due: 12/31/13

Gastric Slow Wave and Autonomic Nervous Function in Cirrhotic Patients With Esophageal Varices After Ligation-A Clinical Research

Phase: N/A Priority: Normal
NCT ID: NCT04125875 Org: User:
Start: 05/23/19 End: 07/31/19 Due: 07/31/20

Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.

Phase: N/A Priority: Normal
NCT ID: NCT06060704 Org: User:
Start: 11/30/23 End: 09/30/25 Due: 09/30/26

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Phase: N/A Priority: Normal
NCT ID: NCT06350825 Org: User:
Start: 01/01/16 End: 12/31/28 Due: 12/31/29

Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06504901 Org: User:
Start: 07/10/24 End: 07/10/27 Due: 07/10/28

Effect of Haemodialysis on the Efficacy of Antiplatelet Agents

Phase: N/A Priority: Normal
NCT ID: NCT03330223 Org: User:
Start: 11/10/17 End: 09/01/19 Due: 09/01/20

Intermittent Darolutamide Treatment in the Triple Therapy of mHSPC

Phase: N/A Priority: Normal
NCT ID: NCT06177015 Org: User:
Start: 12/11/23 End: 12/31/27 Due: 12/31/28

Balloon Catheter Combined With Oxytocin Induction Among the Pregnant Women With Previous Cesarean Section

Phase: N/A Priority: Normal
NCT ID: NCT05246761 Org: User:
Start: 01/30/22 End: 12/30/24 Due: 12/30/25